Cusabio Polyclonal Antibodies
ROS1 Antibody, Biotin conjugated | CSB-PA020072LD01HU
- SKU:
- CSB-PA020072LD01HU
- Availability:
- 3 to 7 Working Days
Description
ROS1 Antibody, Biotin conjugated | CSB-PA020072LD01HU | Cusabio
ROS1 Antibody, Biotin conjugated is Available at Gentaur Genprice with the fastest delivery.
Online Order Payment is possible or send quotation to info@gentaur.com.
Product Type: Polyclonal Antibody
Target Names: ROS1
Aliases: Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase), ROS1, MCF3 ROS
Background: Orphan receptor tyrosine kinase (RTK) that plays a role in epithelial cell differentiation and regionalization of the proximal epididymal epithelium. May activate several downstream signaling pathways related to cell differentiation, proliferation, growth and survival including the PI3 kinase-mTOR signaling pathway. Mediates the phosphorylation of PTPN11, an activator of this pathway. May also phosphorylate and activate the transcription factor STAT3 to control anchorage-independent cell growth. Mediates the phosphorylation and the activation of VAV3, a guanine nucleotide exchange factor regulating cell morphology. May activate other downstream signaling proteins including AKT1, MAPK1, MAPK3, IRS1 and PLCG2.
Isotype: IgG
Conjugate: Biotin
Clonality: Polyclonal
Uniport ID: P08922
Host Species: Rabbit
Species Reactivity: Human
Immunogen: Recombinant Human Proto-oncogene tyrosine-protein kinase ROS protein (79-248AA)
Immunogen Species: Homo sapiens (Human)
Applications: ELISA
Tested Applications: ELISA
Purification Method: >95%, Protein G purified
Dilution Ratio1:
Dilution Ratio2:
Dilution Ratio3:
Dilution Ratio4:
Dilution Ratio5:
Dilution Ratio6:
Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form: Liquid
Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Initial Research Areas: Signal Transduction
Research Areas: Epigenetics & Nuclear Signaling;Cancer;Signal transduction